New drug trial aims to tame angelman syndrome in kids

NCT ID NCT04259281

First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 15 times

Summary

This study tested a new medicine called GTX-102 in 74 children with Angelman Syndrome, a rare genetic disorder causing developmental delays and seizures. The main goal was to see if the drug is safe and tolerable when given as multiple injections into the spine. Researchers monitored side effects and how the drug moves through the body.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANGELMAN SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AP-HP Hopital Necker-Enfants Malades

    Paris, 75015, France

  • Austin Health

    Heidelberg, Victoria, 3084, Australia

  • Boston Children's Hospital

    Boston, Massachusetts, 02115, United States

  • British Columbia Children's Hospital

    Vancouver, British Columbia, V6H3V4, Canada

  • Cambridge University Hospitals

    Cambridge, United Kingdom

  • Children's Hospital of Eastern Ontario

    Ottawa, Ontario, K1H 8L1, Canada

  • Children's Hospital of Western Ontario

    London, Ontario, Canada

  • Great Ormond Street Hospital for Children

    London, United Kingdom

  • Hopital de la Timone

    Marseille, France

  • Hospital Sant Joan de Deu

    Esplugues de Llobregat, Barcelona, Spain

  • Hospital Universitari Parc Tauli

    Sabadell, Barcelona, Spain

  • Hospital Universitario Puerta de Hierro

    Majadahonda, Madrid, Spain

  • MAGIC Clinic Ltd

    Calgary, Alberta, T2E 7Z4, Canada

  • McGill University Health Centre

    Montreal, Quebec, Canada

  • Oxford University Hospitals NHS Foundation Trust

    Oxford, OX3 7LE, United Kingdom

  • Queensland Children's Hospital

    South Brisbane, QLD 4101, Australia

  • Rady Children's Hospital

    San Diego, California, 92123, United States

  • Rare Disease Research

    Atlanta, Georgia, 30318, United States

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • The Edmond and Lily Safra Children's Hospital

    Ramat Gan, Israel

  • The Royal Children's Hospital

    Parkville, Victoria, 3052, Australia

  • UCLA Medical Center

    Los Angeles, California, 90095, United States

  • Universitatsklinikum Hamburg-Eppendorf

    Hamburg, 20246, Germany

  • Universitatsklinikum Leipzig

    Leipzig, Saxony, 04103, Germany

  • Weill Cornell Medicine

    New York, New York, 10065, United States

Conditions

Explore the condition pages connected to this study.